养心颗粒对P53基因转染易损斑块家兔模型血清瘦素含量的影响
|
摘要
目的：探讨养心颗粒对P53基因转染易损斑块家兔模型血清瘦素(Leptin)含量的影响,研究养心颗粒稳定易损斑块的作用机制。
方法：以球囊损伤家兔颈总动脉结合高脂饮食喂养8周,8周末在颈总动脉斑块形成处转染重组人P53腺病毒载体制备易损斑块模型。将模型家兔随机分为模型对照组、养心颗粒组、辛伐他汀组,每组6只,另取6只家兔作为空白对照组；给药2周,10周末药物触发斑块破裂,耳缘静脉取血,用ELISA法检测血清瘦素含量
结果：各模型组在8周末血清瘦素含量升高,与空白对照组相比差异具有统计学意义(P<0.05)；10周末,各治疗组血清瘦素含量降低,与模型对照组相比差异具有统计学意义(P<0.05)；10周末,养心颗粒组血清瘦素含量降低,与辛伐他汀组相比差异具有统计学意义(P<0.05)。
结论：养心颗粒能明显降低P53基因转染易损斑块家兔模型血清瘦素含量,这可能为其稳定易损斑块的作用机制之一。
Objective:To study the effect of Yangxin granule on serum leptin in vulnerable plaque of rabbit model with P53 gene transfection.
Method:Carotid artery wall injuries were induced by intravascular balloon in rabbits. At the end of the 8th week, recombinant adenovirus vector for transfecting P53 gene were injected to plaques of carotid segments. Rabbits were randomly divided into four groups:Model control group, Yangxin granule group, simvastatin group and blank group (6 in each group). Following of administration for two weeks, plaques were ruptured because of pharmacological triggering. At the end of the 8th and 10th weekend, the contents of serum leptin was detected by ELISA method.
Results:Compared with blank group, the content of serum leptin in other groups were obviously increased at the end of the 8th week(P<0.05).Compared with model control group, the content of serum leptin in treatment groups was declined at the end of 10th week. There was significant difference between Yangxin granule group and simvastatin group (P<0.05).The content of serum leptin in Yangxin granule group was lower than that in simvastatin group(P<0.05).
Conclusion:Yangxin granule could remarkably decrease the content of serum leptin in vulnerable plaque of rabbit model with P53 gene transfection, which might be one of the mechanisms for stabilizing vulnerable plaque.
方法：以球囊损伤家兔颈总动脉结合高脂饮食喂养8周,8周末在颈总动脉斑块形成处转染重组人P53腺病毒载体制备易损斑块模型。将模型家兔随机分为模型对照组、养心颗粒组、辛伐他汀组,每组6只,另取6只家兔作为空白对照组；给药2周,10周末药物触发斑块破裂,耳缘静脉取血,用ELISA法检测血清瘦素含量
结果：各模型组在8周末血清瘦素含量升高,与空白对照组相比差异具有统计学意义(P<0.05)；10周末,各治疗组血清瘦素含量降低,与模型对照组相比差异具有统计学意义(P<0.05)；10周末,养心颗粒组血清瘦素含量降低,与辛伐他汀组相比差异具有统计学意义(P<0.05)。
结论：养心颗粒能明显降低P53基因转染易损斑块家兔模型血清瘦素含量,这可能为其稳定易损斑块的作用机制之一。
Objective:To study the effect of Yangxin granule on serum leptin in vulnerable plaque of rabbit model with P53 gene transfection.
Method:Carotid artery wall injuries were induced by intravascular balloon in rabbits. At the end of the 8th week, recombinant adenovirus vector for transfecting P53 gene were injected to plaques of carotid segments. Rabbits were randomly divided into four groups:Model control group, Yangxin granule group, simvastatin group and blank group (6 in each group). Following of administration for two weeks, plaques were ruptured because of pharmacological triggering. At the end of the 8th and 10th weekend, the contents of serum leptin was detected by ELISA method.
Results:Compared with blank group, the content of serum leptin in other groups were obviously increased at the end of the 8th week(P<0.05).Compared with model control group, the content of serum leptin in treatment groups was declined at the end of 10th week. There was significant difference between Yangxin granule group and simvastatin group (P<0.05).The content of serum leptin in Yangxin granule group was lower than that in simvastatin group(P<0.05).
Conclusion:Yangxin granule could remarkably decrease the content of serum leptin in vulnerable plaque of rabbit model with P53 gene transfection, which might be one of the mechanisms for stabilizing vulnerable plaque.
引文
[1]Smith SC. Risk reduction therapy:The challenge to change Circulation 1996:93:2205-2211.
[2]费瑜,宋春莉,刘铁成等.肥胖的不稳定型心绞痛患者血清瘦素水平的变化[J].Chin J Crit Care Med,2005,25 (5):382.
[3]李树岩,费瑜,刘铁成等.不稳定型心绞痛血清瘦素水平的变化及冠状动脉支架置入术对其影响[J]. 中国老年学杂志,2005,11(25)：1319.
[4]吴薇薇,纪树岚.冠心病患者治疗前后血清leptin、FA和VitB12水平变化的临床意义[J].放射免疫学杂志,20008,21(5)：397.
[5]孙静养心颗粒对近似不稳定型心绞痛模型颈总动脉PDGF-B mRNA和VEGF mRNA影响的研究黑龙江中医药大学博士论文.2008
[6]李济仁,李梢今,李艳.冠心病诊治经验[J].中医杂志,1994,35(8)：465-466.
[7]林晓忠,严夏,王侠,等.生脉逐瘀汤治疗冠心病心绞痛临床观察[J].中国中医药信息杂志,2000,7(8)：64-65.
[8]孟宪宗.周信有教授辨治冠心病经验[J].甘肃中医学院学报,2007,24(2)：1-3.
[9]李洁.冠心病心绞痛从痰瘀论治[J].陕西中医,2001,22(2)：96-97.
[10]王永炎.中医内科学[M].6版.上海：上海科学技术出版社,1997：108-117
[11]周仲瑛.中医内科学[M].7版.北京：中医药出版社,2007： 135-146.
[12]中华人民共和国卫生部.中药新药临床研究指导原则[S].北京：人民卫生出版社,1993：41-45.
[13]李俊,李小敏,刘映峰,等.冠心病冠状动脉造影结果与中医证型及血脂、脂蛋自关系的研究[J].中国中医急症,2000,9(3)：123-124.
[14]张桂明.冠心病心绞痛从虚实论治[J].长春中医学院学报,1994,10(45)：8.
[15]王阶,李军等. 冠心病心绞痛证候要素和冠脉病变的Logistic回归分析[J]辽宁中医杂志.2007,34(9)：1209-1211
[16]车红花.冠心病证候特征研究[D]辽宁中医药大学.2009
[17]李俊,王大伟等.冠心病不稳定型心绞痛中医证候与C-反应蛋白和基质金属蛋白酶-9关系的研究.[J] 辽宁中医药大学学报.2008,10(2)：102-103
[18]李杨帆,齐昉等.不稳定心绞痛患者不同中医证候的血浆FIB水平回顾性分析[J]首都医科大学学报.2008,29(2)：181-183
[19]韩丽蓓,杨惠民等.老年前期及老年人血脂代谢紊乱与中医证候的相关性研究[J]北京中医药大学学报.2005,28(4)：77-79
[20]邢雁伟,李尊. 冠脉病变特征和中医证候要素关系的研究[J]辽宁中医杂志.2008,35(1)：36
[21]刘红旭,王振裕.[C]北京中医医院113例冠状动脉造影患者中医证候与造影特点分析.北京：第二届国际中医心病学术研讨会,2005：183
[22]杨阳,李方洁.冠心病中医证候及脾虚痰浊证与冠脉病变的关系对比观察[J]中华中医药杂志.2010,25(3)：352-354
[23]文川,徐浩,黄启福,等.活血中药对ApoE基因缺陷小鼠血脂及动脉粥样硬化斑块炎症反应的影响[J].
[24]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[25]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白 E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[26]姜希卷、杜云、苏金玲等.心脑血脉宁对家兔易损斑块模型血清CRP和斑块内炎性细胞浸润的影响[J]天津中医药,2007,24(5)：402-407
[27]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白 E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[28]黄晓松、杨期东、龙光喻等.通心络胶囊对颈动脉粥样硬化不稳定斑块影响的临床研究[J]疑难病杂志,2007,6,(5)：267-269
[29]毕轶、马亚兵、高海青.通心络抗动脉粥样硬化研究进展[J]中国心血 管杂志.2005,10(2)： 142-143
[30]刘剑刚,董国菊,史大卓,等.气血并治方提取物对ApoE基因缺陷小鼠动脉粥样硬化病理形态和基质金属蛋白酶-1及其抑制物表达的影响[J].中国药学杂志,2008,43(22)：1700-1705.
[31]尚德师、张淼、陈咸川等.化湿泄浊汤对不稳定心绞痛患者高敏C反应蛋白影响的临床研究[J]时珍国医国药,2007,18(2)：421-422
[32]刘运芳,赵玉霞,于会明,等.祛瘀消斑胶囊对实验性动脉粥样硬化斑块组织学构成的影响[J].上海中医药大学学报,2005, 19(3)：34-35
[33]赵玉霞,刘运芳,刘艳,等.祛瘀消斑胶囊对易损斑块的稳定作用[J].中医杂志,2006,47(11)：856-858.
[34]张京春,陈可冀,刘剑刚,等.解毒活血配伍方药对载脂蛋白E基因敲除小鼠血清超敏C反应蛋白的影响[J].中国中西医结合杂志,2008,28(4)： 330-333.
[35]张京春,陈可冀,郑广娟,等.解毒活血中药配伍对载脂蛋白E基因敲除小鼠主动脉NF-κ B和MMP-9表达的调控作用[J].中国中西医结合杂志,2007,27(1)：40-44.
[36]徐蓉, 叶秀琳,何淑娴.清热解毒活血化淤法对急性冠脉综合征患者血清sCD40L的影响[J]中医药导报,2006,12(7)：12-13
[37]李天奇,李勇,范维琥.麝香保心丸和辛伐他汀对兔股动脉粥样硬化斑块稳定性的影响[J].中华老年心脑血管病杂志,2006,8(5)：296-299
[38]徐立新,李美,张素燕.麝香保心丸对老年冠心病病人血清E-选择素、P选择素、sICAM-1、sVCAM-1的影响[J].中药药理与临床,2005,21(1)：54-55
[39]Muller J, Tofler G, Stone P. Ciradian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79; 733-743
[40]Li Ling, shen ZQ, Chen ZH, et al. Neuroprotective effects in gerbils of spiramine T from spirea japonica var acuta[J]. Planta Medica, 2001,67(1):142-145
[41]金惠铭,主编.病理生理学[M].北京：人民卫生出版社,2004：151-153
[42]Moreno PR, Lodder RA. Detection of lipid pool thin fibrous cap,and inflammatory cells in human aortic atherosclerotic plaques by near infarcted spectroscopy [J]. Circulation,2002,105 (8):923-927.
[43]黄体钢.不稳定型心绞痛的病理生理机制和血清标志物水平变化的临床意义[M].黄体钢,丛洪良,张承宗,主编.心脏病学高级教程.沈阳：辽宁科学技术出版社,2003.84-94.
[44]Meuwissen M, VanderWal AC,Niessen HW, etal. Colocalisation of intraplaque C reactive protein, complement, oxidized low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction[J]. J C lin Pathol 2006,59(2):196-201.
[45]Fuster V. Human lesion studies [J]. Ann N Y Acad Sci 1997,811: 207-225.
[46]Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes partIV:matrix metallop roteinases and biomarkers of plateletactivation [J]. Circulation,2006,113(3): 382-385.
[47]韦立新.不稳定斑块破裂的形态学及发生机制的病理学研究进展[J].国外医学(生理、病理科学与临床分册),2003,23(5)：441-443.
[48]Stefanadis C, Toutouzas K, Tsiam is E, et al Increased local temperature in human coronary atherosclerotic plaques:an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention [J]. J Am Coll Cardiol 2001,37:1277-1283.
[49]Meuwissen M, VanderWal AC,Niessen HW, etal. Colocalisation of intraplaque C reactive protein, complement, oxidized low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction[J]. J C lin Pathol 2006,59(2):196-201.
[50]VirmaniR, Burke AP, Farb A, et al. Pathology of the vulnerable plaque[J]. JAm CollCardiol 2006,47(8 Suppl):C13-18.
[51]胡大一,黄元铸.急性冠状动脉综合征[M].北京：人民卫生出版社,2001.5-37.
[52]郭爱桃,韦立新.基质金属蛋白酶-1与冠状动脉粥样硬化斑块破裂的 关系[J].中华病理学杂志,2000,29：263-266。
[53]Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability [J]. Circulation, 2002,105(8):939-943.)
[54]Lemaitre V, Soloway PD, Armiento J, et al. Increased medial degradation with pseudo aneurysm formation in apolipoprotein knockout mice deficient in tissue inhibitor of metalloproteinases-1 [J]. Circulation,2003,107:333-33
[55]Kockx MM. Apoptosis in the atherosclerotic plaque:quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol,1998,18:1 519-522
[56]Vonder Thusen JH, van Vlijmen BJ, Hoeben RC, Kockx MM, Havekes LM van. Induction of atherosclerotic plaque rupture in apolipoprotein E-/-mice after adenovirus-mediated transfer of P53 [J]. Circulation, 2002,105(17):2064-070
[57]Himshi M, Abe E, Fisher EA, Zaidi M, Fallon JT. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice[J].BiochemBiophys Res Commun,2005, 328(3):790-793
[58]Caligiuri G, Levy B, PernowJ, ThorenP, HanssonGK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice [J]. ProcNatlAcadSci USA,1999,96(12):6 920-924
[59]Constantinides P, Chakravarti RH.Rabbit arterial thrombosis production by systemic procedures [J]. ArchPathol,1961,72:197-208
[60]Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M.Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model [J]. Circulation,1995,91(3):776-78
[61]扬永宗.中国动脉粥样硬化病理生理学研究近况[J].中国动脉硬化杂志,2004,12(4)：481-489
[62]陈文强,张运,张梅,季晓平,林晨,朱永峰,等.外源性人野生型P53基 因转染导致兔动脉硬化斑块的不稳定性[J].中华医学杂志,2004,84：43-47
[63]Pakala R,Leborgne L,Cheneau E,Chan RC,YazadiH,Fournadjiev J,et al. Radiation-induced atherosclerotic plaque progression in a hypercholeste-rolemic rabbit:aprospective vulnerableplaque model[J] Cardiovasc Radiat Med,2003,4(3):146-15
[64]胡琴,张运.易损斑块动物模型的研究进展[J].Chin J Arterioscler, Vol 14, No9:820-822
[65]Prescott MF, McBride CH, Hasle-Rapacz J, Thoren P, Hansson GK. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B [J]. Am J Pathol,1991,139(1):139-147
[66]HerreraVL, Makrides SL, XieHX, Adari H, Krauss RM, Ryan US, et al. Spotaneous combined hyperlipidemia, coronary heart disease and decreased survival inDahl salt-sensitive hypertensiverats transgenic forhuman cholesteryl estertransfer protein [J]. NatMed,1999,5(12):1 383-389
[67]Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, et al. Peripheral vascular stenosis in apolipoprotein E-deficient mice.Potential roles of lipid deposition, medial atrophy, and adventitial inflammation[J]. ArteriosclerThromb Vasc Biol, 1997,17(12):3593-60
[68]Rosenfeld ME, PolinskyP, Virmani R, KauserK, Rubanyi G, Schwartz SM, et al.Advanced atherosclerotic lesions in the innominate artery of the ApoEknockout mouse [J]. ArteriosclerThromb Vasc Biol, 2000,20(12):2 587-592
[69]Williams H, Johnson JL, CarsonKG, JacksonKL. Characteristic of intact and ruptured atherosclerotic plaque in brachiocephalic arteries of apolipoprotein E knockout mice [J].ArteriosclerThromb Vase Biol, 2002,22(5):788-792
[70]Considine RVet al.N Engl J Med,1995,334:292-295.
[71]Pelleymounter MAet al.Science,1995,269:540-543.
[72]Halaas JL et al.Science,1995,269:543-546.
[73]Erickson JCet al.Science,1996,274:1704-1707.
[74]Campfied LA et al.Horm Metab Res,1996,28:619-632.
[75]Fan Wet al.Nature,1997,385:165-168.
[76]Kristensen P et al.Nature,1998,393:72-76.
[77]Williams G,Harrold J A,Cutler D J,et al.The hypothalamus and the regulation of energy homeostasis:lifting the lid on a black box[J].Proc Nutr Soc,2000,59:385-396.
[78]Halaas JL et al.Science,1995,269:543-546.
[79]Collins Set al.Nature,1996,380:677.
[80]Fruhbeck Get al.Biochem Biophys Res Commun,1997,240:590-594.
[81]Sarmiento Uet al.Lab Invest,1997,77:243-256.
[82]nger RH, Zhou YT.Proc Natl Acad Sci USA,1999,96:2327-2332.
[83]Shimomura I,Hammer R E,Ikemoto S,et al.Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipdystrophy [J].Nature,1999,401:73-76.
[84]Kieffer TJ et al.Diabetes,1997,46:1087-1093.
[85]Carro E et al.Endocrinology,1997,138:2203-2206.
[86]Huang QL et al.Endocrinology,1998,139:1524-1532.
[87]Chehab FFet al.Genet,1996,12:318-320.
[88]Vogel G.Science,1996,274:1466-1467.
[89]Horlick M B,Rosenbaum M,Nicolson M,et al.Effect of puberty on relationship between circulation leptin and body composition[J].J Clin Endocrinol Metab,2000,85:2509-2518.
[90]Mantzoros C S.Role of leptin in reproduction. Ann N Y A-cad Sci,2000,900:1742183.
[91]Sabogal JC.Obstet Gynecol Surv,2001,56:225-230.
[92]Elmquist J K,Bjorbaek C,Ahima R S,et al.Distribution of leptin receptor mRNA isforms in rat brain[J].J Comp Neu rol,1998,395: 5352547.
[93]Sierra-Honigmann MR et al.Science,1998,281:897-901.
[94]Han DCet al.Kidney Int,2001,59:1315-1323.
[95]Graham Met al.Nature,1998,394:897-901.
[96]Fruhbeek G.Pivotal role of nitric oxide in the control of blood presure after leptin administration[J]. Diabetes,1999,48:903-908.
[97]Kimura K,Tsuda K,Baba A,et al.Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin [J]. Biochem Biophys Res Commun,2000,273:745-749.
[98]Lyon CJ,Law RE, H sueh WA,et al.Minireview:adiposity inflammation and atherogenesis[J].Endocrinology,2003; 144:2195-200.
[99]Nakata M,Yada T,Soejima N,et al.Leptin promotes aggregation of human platelets via the long form of its receptor [J].Diabetes, 1999,48:426-429
[100]费瑜,宋春莉,刘铁成等.肥胖的不稳定型心绞痛患者血清瘦素水平的变化[J].Chin J Crit Care Med,2005,25 (5):382.
[101]李树岩,费瑜,刘铁成等.不稳定型心绞痛血清瘦素水平的变化及冠状动脉支架置入术对其影响[J].中国老年学杂志,2005,11(25)：1319.
[102]吴薇薇,纪树岚.冠心病患者治疗前后血清leptin、FA和VitB12水平变化的临床意义[J].放射免疫学杂志,20008,21(5)：397.
[103]张文琪,孙福山,费瑜等.冠状动脉介入治疗术对肥胖的不稳定性心绞痛患者血清瘦素水平的影响及丹参粉针对其干预[J]. Chin J Lab Diagn,December,2006,10(12):1436.
[104]赵忠谱,王莉,费瑜,等.辛伐他汀对老年冠状动脉支架植入术的不稳定性心绞痛患者血清瘦素水平的影响[J]中国老年学杂志,2005,11(25)：1324
[105]丁水印,万平,王留义等,急性冠脉综合征患者肥胖与血.清瘦素水平关系研究[J]. Journal of Medical Forum,2006,27 (16):57
[106]罗南萍,胡成进,孙晓明等[J].放射免疫学杂志,2005,18(3)：163.
[107]蒋乃,君唐珍.世界卫生组织报告全球生存现状[J] 决策与信息.2007,7：8
[108]张愍.冠心病痰浊辩证分型与血清脂蛋白动态平衡关系的研究[J]中西医结合杂志,1995,15(1)：9～10)
[109]刘影哲,周亚滨.养心汤对家兔不稳定型心肌缺血模型血浆TXB2含量及颈总动脉内中膜厚度的影响[J]. 中西医结合心血管病杂志2006,4(12),1067-1068
[110]客蕊.养心颗粒对实验性快速型心律失常模型心肌ATP敏感性钾通道影响的研究.黑龙江中医药大学博士论文.2009
[111]刘影哲.养心颗粒治疗冠心病心律失常及不稳定型心绞痛的实验研究黑龙江中医药大学博士论文.2007.
[112]孙静,姚凤祯.养心汤对家兔不稳定型心绞痛模型心肌细胞凋亡的影响[J].中医药信息2008,25(3),62-63)
[113]刘影哲,周亚滨,韩佳瑞.养心汤对不稳定型心绞痛家兔血浆前列腺素及主动脉、 心肌超微结构的影响[J].中国中医药科技2006,13(1)24-25
[114]吴桐菲,周亚滨.养心颗粒对冠心病心律失常模型家兔丙二醛的影响[J].中西医结合心脑血管病杂志2008,6(2),163-164
[2]费瑜,宋春莉,刘铁成等.肥胖的不稳定型心绞痛患者血清瘦素水平的变化[J].Chin J Crit Care Med,2005,25 (5):382.
[3]李树岩,费瑜,刘铁成等.不稳定型心绞痛血清瘦素水平的变化及冠状动脉支架置入术对其影响[J]. 中国老年学杂志,2005,11(25)：1319.
[4]吴薇薇,纪树岚.冠心病患者治疗前后血清leptin、FA和VitB12水平变化的临床意义[J].放射免疫学杂志,20008,21(5)：397.
[5]孙静养心颗粒对近似不稳定型心绞痛模型颈总动脉PDGF-B mRNA和VEGF mRNA影响的研究黑龙江中医药大学博士论文.2008
[6]李济仁,李梢今,李艳.冠心病诊治经验[J].中医杂志,1994,35(8)：465-466.
[7]林晓忠,严夏,王侠,等.生脉逐瘀汤治疗冠心病心绞痛临床观察[J].中国中医药信息杂志,2000,7(8)：64-65.
[8]孟宪宗.周信有教授辨治冠心病经验[J].甘肃中医学院学报,2007,24(2)：1-3.
[9]李洁.冠心病心绞痛从痰瘀论治[J].陕西中医,2001,22(2)：96-97.
[10]王永炎.中医内科学[M].6版.上海：上海科学技术出版社,1997：108-117
[11]周仲瑛.中医内科学[M].7版.北京：中医药出版社,2007： 135-146.
[12]中华人民共和国卫生部.中药新药临床研究指导原则[S].北京：人民卫生出版社,1993：41-45.
[13]李俊,李小敏,刘映峰,等.冠心病冠状动脉造影结果与中医证型及血脂、脂蛋自关系的研究[J].中国中医急症,2000,9(3)：123-124.
[14]张桂明.冠心病心绞痛从虚实论治[J].长春中医学院学报,1994,10(45)：8.
[15]王阶,李军等. 冠心病心绞痛证候要素和冠脉病变的Logistic回归分析[J]辽宁中医杂志.2007,34(9)：1209-1211
[16]车红花.冠心病证候特征研究[D]辽宁中医药大学.2009
[17]李俊,王大伟等.冠心病不稳定型心绞痛中医证候与C-反应蛋白和基质金属蛋白酶-9关系的研究.[J] 辽宁中医药大学学报.2008,10(2)：102-103
[18]李杨帆,齐昉等.不稳定心绞痛患者不同中医证候的血浆FIB水平回顾性分析[J]首都医科大学学报.2008,29(2)：181-183
[19]韩丽蓓,杨惠民等.老年前期及老年人血脂代谢紊乱与中医证候的相关性研究[J]北京中医药大学学报.2005,28(4)：77-79
[20]邢雁伟,李尊. 冠脉病变特征和中医证候要素关系的研究[J]辽宁中医杂志.2008,35(1)：36
[21]刘红旭,王振裕.[C]北京中医医院113例冠状动脉造影患者中医证候与造影特点分析.北京：第二届国际中医心病学术研讨会,2005：183
[22]杨阳,李方洁.冠心病中医证候及脾虚痰浊证与冠脉病变的关系对比观察[J]中华中医药杂志.2010,25(3)：352-354
[23]文川,徐浩,黄启福,等.活血中药对ApoE基因缺陷小鼠血脂及动脉粥样硬化斑块炎症反应的影响[J].
[24]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[25]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白 E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[26]姜希卷、杜云、苏金玲等.心脑血脉宁对家兔易损斑块模型血清CRP和斑块内炎性细胞浸润的影响[J]天津中医药,2007,24(5)：402-407
[27]徐浩、文川,陈可翼等. 赤芍、川芎及其有效配伍部位配伍对载脂蛋白 E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J]中国中西医结合杂志,2007,27(6)：513-518
[28]黄晓松、杨期东、龙光喻等.通心络胶囊对颈动脉粥样硬化不稳定斑块影响的临床研究[J]疑难病杂志,2007,6,(5)：267-269
[29]毕轶、马亚兵、高海青.通心络抗动脉粥样硬化研究进展[J]中国心血 管杂志.2005,10(2)： 142-143
[30]刘剑刚,董国菊,史大卓,等.气血并治方提取物对ApoE基因缺陷小鼠动脉粥样硬化病理形态和基质金属蛋白酶-1及其抑制物表达的影响[J].中国药学杂志,2008,43(22)：1700-1705.
[31]尚德师、张淼、陈咸川等.化湿泄浊汤对不稳定心绞痛患者高敏C反应蛋白影响的临床研究[J]时珍国医国药,2007,18(2)：421-422
[32]刘运芳,赵玉霞,于会明,等.祛瘀消斑胶囊对实验性动脉粥样硬化斑块组织学构成的影响[J].上海中医药大学学报,2005, 19(3)：34-35
[33]赵玉霞,刘运芳,刘艳,等.祛瘀消斑胶囊对易损斑块的稳定作用[J].中医杂志,2006,47(11)：856-858.
[34]张京春,陈可冀,刘剑刚,等.解毒活血配伍方药对载脂蛋白E基因敲除小鼠血清超敏C反应蛋白的影响[J].中国中西医结合杂志,2008,28(4)： 330-333.
[35]张京春,陈可冀,郑广娟,等.解毒活血中药配伍对载脂蛋白E基因敲除小鼠主动脉NF-κ B和MMP-9表达的调控作用[J].中国中西医结合杂志,2007,27(1)：40-44.
[36]徐蓉, 叶秀琳,何淑娴.清热解毒活血化淤法对急性冠脉综合征患者血清sCD40L的影响[J]中医药导报,2006,12(7)：12-13
[37]李天奇,李勇,范维琥.麝香保心丸和辛伐他汀对兔股动脉粥样硬化斑块稳定性的影响[J].中华老年心脑血管病杂志,2006,8(5)：296-299
[38]徐立新,李美,张素燕.麝香保心丸对老年冠心病病人血清E-选择素、P选择素、sICAM-1、sVCAM-1的影响[J].中药药理与临床,2005,21(1)：54-55
[39]Muller J, Tofler G, Stone P. Ciradian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79; 733-743
[40]Li Ling, shen ZQ, Chen ZH, et al. Neuroprotective effects in gerbils of spiramine T from spirea japonica var acuta[J]. Planta Medica, 2001,67(1):142-145
[41]金惠铭,主编.病理生理学[M].北京：人民卫生出版社,2004：151-153
[42]Moreno PR, Lodder RA. Detection of lipid pool thin fibrous cap,and inflammatory cells in human aortic atherosclerotic plaques by near infarcted spectroscopy [J]. Circulation,2002,105 (8):923-927.
[43]黄体钢.不稳定型心绞痛的病理生理机制和血清标志物水平变化的临床意义[M].黄体钢,丛洪良,张承宗,主编.心脏病学高级教程.沈阳：辽宁科学技术出版社,2003.84-94.
[44]Meuwissen M, VanderWal AC,Niessen HW, etal. Colocalisation of intraplaque C reactive protein, complement, oxidized low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction[J]. J C lin Pathol 2006,59(2):196-201.
[45]Fuster V. Human lesion studies [J]. Ann N Y Acad Sci 1997,811: 207-225.
[46]Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes partIV:matrix metallop roteinases and biomarkers of plateletactivation [J]. Circulation,2006,113(3): 382-385.
[47]韦立新.不稳定斑块破裂的形态学及发生机制的病理学研究进展[J].国外医学(生理、病理科学与临床分册),2003,23(5)：441-443.
[48]Stefanadis C, Toutouzas K, Tsiam is E, et al Increased local temperature in human coronary atherosclerotic plaques:an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention [J]. J Am Coll Cardiol 2001,37:1277-1283.
[49]Meuwissen M, VanderWal AC,Niessen HW, etal. Colocalisation of intraplaque C reactive protein, complement, oxidized low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction[J]. J C lin Pathol 2006,59(2):196-201.
[50]VirmaniR, Burke AP, Farb A, et al. Pathology of the vulnerable plaque[J]. JAm CollCardiol 2006,47(8 Suppl):C13-18.
[51]胡大一,黄元铸.急性冠状动脉综合征[M].北京：人民卫生出版社,2001.5-37.
[52]郭爱桃,韦立新.基质金属蛋白酶-1与冠状动脉粥样硬化斑块破裂的 关系[J].中华病理学杂志,2000,29：263-266。
[53]Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability [J]. Circulation, 2002,105(8):939-943.)
[54]Lemaitre V, Soloway PD, Armiento J, et al. Increased medial degradation with pseudo aneurysm formation in apolipoprotein knockout mice deficient in tissue inhibitor of metalloproteinases-1 [J]. Circulation,2003,107:333-33
[55]Kockx MM. Apoptosis in the atherosclerotic plaque:quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol,1998,18:1 519-522
[56]Vonder Thusen JH, van Vlijmen BJ, Hoeben RC, Kockx MM, Havekes LM van. Induction of atherosclerotic plaque rupture in apolipoprotein E-/-mice after adenovirus-mediated transfer of P53 [J]. Circulation, 2002,105(17):2064-070
[57]Himshi M, Abe E, Fisher EA, Zaidi M, Fallon JT. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice[J].BiochemBiophys Res Commun,2005, 328(3):790-793
[58]Caligiuri G, Levy B, PernowJ, ThorenP, HanssonGK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice [J]. ProcNatlAcadSci USA,1999,96(12):6 920-924
[59]Constantinides P, Chakravarti RH.Rabbit arterial thrombosis production by systemic procedures [J]. ArchPathol,1961,72:197-208
[60]Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M.Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model [J]. Circulation,1995,91(3):776-78
[61]扬永宗.中国动脉粥样硬化病理生理学研究近况[J].中国动脉硬化杂志,2004,12(4)：481-489
[62]陈文强,张运,张梅,季晓平,林晨,朱永峰,等.外源性人野生型P53基 因转染导致兔动脉硬化斑块的不稳定性[J].中华医学杂志,2004,84：43-47
[63]Pakala R,Leborgne L,Cheneau E,Chan RC,YazadiH,Fournadjiev J,et al. Radiation-induced atherosclerotic plaque progression in a hypercholeste-rolemic rabbit:aprospective vulnerableplaque model[J] Cardiovasc Radiat Med,2003,4(3):146-15
[64]胡琴,张运.易损斑块动物模型的研究进展[J].Chin J Arterioscler, Vol 14, No9:820-822
[65]Prescott MF, McBride CH, Hasle-Rapacz J, Thoren P, Hansson GK. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B [J]. Am J Pathol,1991,139(1):139-147
[66]HerreraVL, Makrides SL, XieHX, Adari H, Krauss RM, Ryan US, et al. Spotaneous combined hyperlipidemia, coronary heart disease and decreased survival inDahl salt-sensitive hypertensiverats transgenic forhuman cholesteryl estertransfer protein [J]. NatMed,1999,5(12):1 383-389
[67]Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, et al. Peripheral vascular stenosis in apolipoprotein E-deficient mice.Potential roles of lipid deposition, medial atrophy, and adventitial inflammation[J]. ArteriosclerThromb Vasc Biol, 1997,17(12):3593-60
[68]Rosenfeld ME, PolinskyP, Virmani R, KauserK, Rubanyi G, Schwartz SM, et al.Advanced atherosclerotic lesions in the innominate artery of the ApoEknockout mouse [J]. ArteriosclerThromb Vasc Biol, 2000,20(12):2 587-592
[69]Williams H, Johnson JL, CarsonKG, JacksonKL. Characteristic of intact and ruptured atherosclerotic plaque in brachiocephalic arteries of apolipoprotein E knockout mice [J].ArteriosclerThromb Vase Biol, 2002,22(5):788-792
[70]Considine RVet al.N Engl J Med,1995,334:292-295.
[71]Pelleymounter MAet al.Science,1995,269:540-543.
[72]Halaas JL et al.Science,1995,269:543-546.
[73]Erickson JCet al.Science,1996,274:1704-1707.
[74]Campfied LA et al.Horm Metab Res,1996,28:619-632.
[75]Fan Wet al.Nature,1997,385:165-168.
[76]Kristensen P et al.Nature,1998,393:72-76.
[77]Williams G,Harrold J A,Cutler D J,et al.The hypothalamus and the regulation of energy homeostasis:lifting the lid on a black box[J].Proc Nutr Soc,2000,59:385-396.
[78]Halaas JL et al.Science,1995,269:543-546.
[79]Collins Set al.Nature,1996,380:677.
[80]Fruhbeck Get al.Biochem Biophys Res Commun,1997,240:590-594.
[81]Sarmiento Uet al.Lab Invest,1997,77:243-256.
[82]nger RH, Zhou YT.Proc Natl Acad Sci USA,1999,96:2327-2332.
[83]Shimomura I,Hammer R E,Ikemoto S,et al.Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipdystrophy [J].Nature,1999,401:73-76.
[84]Kieffer TJ et al.Diabetes,1997,46:1087-1093.
[85]Carro E et al.Endocrinology,1997,138:2203-2206.
[86]Huang QL et al.Endocrinology,1998,139:1524-1532.
[87]Chehab FFet al.Genet,1996,12:318-320.
[88]Vogel G.Science,1996,274:1466-1467.
[89]Horlick M B,Rosenbaum M,Nicolson M,et al.Effect of puberty on relationship between circulation leptin and body composition[J].J Clin Endocrinol Metab,2000,85:2509-2518.
[90]Mantzoros C S.Role of leptin in reproduction. Ann N Y A-cad Sci,2000,900:1742183.
[91]Sabogal JC.Obstet Gynecol Surv,2001,56:225-230.
[92]Elmquist J K,Bjorbaek C,Ahima R S,et al.Distribution of leptin receptor mRNA isforms in rat brain[J].J Comp Neu rol,1998,395: 5352547.
[93]Sierra-Honigmann MR et al.Science,1998,281:897-901.
[94]Han DCet al.Kidney Int,2001,59:1315-1323.
[95]Graham Met al.Nature,1998,394:897-901.
[96]Fruhbeek G.Pivotal role of nitric oxide in the control of blood presure after leptin administration[J]. Diabetes,1999,48:903-908.
[97]Kimura K,Tsuda K,Baba A,et al.Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin [J]. Biochem Biophys Res Commun,2000,273:745-749.
[98]Lyon CJ,Law RE, H sueh WA,et al.Minireview:adiposity inflammation and atherogenesis[J].Endocrinology,2003; 144:2195-200.
[99]Nakata M,Yada T,Soejima N,et al.Leptin promotes aggregation of human platelets via the long form of its receptor [J].Diabetes, 1999,48:426-429
[100]费瑜,宋春莉,刘铁成等.肥胖的不稳定型心绞痛患者血清瘦素水平的变化[J].Chin J Crit Care Med,2005,25 (5):382.
[101]李树岩,费瑜,刘铁成等.不稳定型心绞痛血清瘦素水平的变化及冠状动脉支架置入术对其影响[J].中国老年学杂志,2005,11(25)：1319.
[102]吴薇薇,纪树岚.冠心病患者治疗前后血清leptin、FA和VitB12水平变化的临床意义[J].放射免疫学杂志,20008,21(5)：397.
[103]张文琪,孙福山,费瑜等.冠状动脉介入治疗术对肥胖的不稳定性心绞痛患者血清瘦素水平的影响及丹参粉针对其干预[J]. Chin J Lab Diagn,December,2006,10(12):1436.
[104]赵忠谱,王莉,费瑜,等.辛伐他汀对老年冠状动脉支架植入术的不稳定性心绞痛患者血清瘦素水平的影响[J]中国老年学杂志,2005,11(25)：1324
[105]丁水印,万平,王留义等,急性冠脉综合征患者肥胖与血.清瘦素水平关系研究[J]. Journal of Medical Forum,2006,27 (16):57
[106]罗南萍,胡成进,孙晓明等[J].放射免疫学杂志,2005,18(3)：163.
[107]蒋乃,君唐珍.世界卫生组织报告全球生存现状[J] 决策与信息.2007,7：8
[108]张愍.冠心病痰浊辩证分型与血清脂蛋白动态平衡关系的研究[J]中西医结合杂志,1995,15(1)：9～10)
[109]刘影哲,周亚滨.养心汤对家兔不稳定型心肌缺血模型血浆TXB2含量及颈总动脉内中膜厚度的影响[J]. 中西医结合心血管病杂志2006,4(12),1067-1068
[110]客蕊.养心颗粒对实验性快速型心律失常模型心肌ATP敏感性钾通道影响的研究.黑龙江中医药大学博士论文.2009
[111]刘影哲.养心颗粒治疗冠心病心律失常及不稳定型心绞痛的实验研究黑龙江中医药大学博士论文.2007.
[112]孙静,姚凤祯.养心汤对家兔不稳定型心绞痛模型心肌细胞凋亡的影响[J].中医药信息2008,25(3),62-63)
[113]刘影哲,周亚滨,韩佳瑞.养心汤对不稳定型心绞痛家兔血浆前列腺素及主动脉、 心肌超微结构的影响[J].中国中医药科技2006,13(1)24-25
[114]吴桐菲,周亚滨.养心颗粒对冠心病心律失常模型家兔丙二醛的影响[J].中西医结合心脑血管病杂志2008,6(2),163-164